» Articles » PMID: 22060250

Attention Modification in Persons with Fibromyalgia: a Double Blind, Randomized Clinical Trial

Overview
Journal Cogn Behav Ther
Date 2011 Nov 9
PMID 22060250
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Contemporary models of chronic musculoskeletal pain emphasize the critical roles of fear, anxiety, and avoidance as well as biases in attention in the development and maintenance of chronic pain disability. Evidence supports the influence of individual difference variables such as anxiety sensitivity, pain-related anxiety, and catastrophizing on the pain experience and on pain-related attentional biases. Changes in attentional biases have been associated with treatment gains in patients with clinically significant anxiety. The Attentional Modification Paradigm (AMP) is a modification of the dot-probe paradigm used to facilitate such changes in attentional biases. Given the relationship between chronic musculoskeletal pain and anxiety, AMP may be effective in reducing pain as well. Participants included persons (n = 17) with fibromyalgia and were randomly assigned to either an AMP condition or a control condition. The participants completed two 15-minute AMP sessions per week for 4 weeks. Those in the AMP condition reported statistically significant and substantial reductions on several individual difference variables relative to those in the control condition, and a greater proportion experienced clinically significant reductions in pain. These preliminary results offer a promising new avenue for treating chronic musculoskeletal pain that warrants additional research. Comprehensive results, limitations, and future directions are discussed.

Citing Articles

Gamified Web-Delivered Attentional Bias Modification Training for Adults With Chronic Pain: Randomized, Double-Blind, Placebo-Controlled Trial.

Vermeir J, White M, Johnson D, Crombez G, Van Ryckeghem D JMIR Serious Games. 2025; 13:e50635.

PMID: 39819575 PMC: 11783034. DOI: 10.2196/50635.


A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.

Wolkowicz N, Sofuoglu M, Pittman B, Meyerovich J, MacLean R, Aquino J J Psychiatr Res. 2024; 177:90-95.

PMID: 38991269 PMC: 11371499. DOI: 10.1016/j.jpsychires.2024.06.047.


Beyond the Pain: A Systematic Narrative Review of the Latest Advancements in Fibromyalgia Treatment.

Ram P, Jeyaraman M, Jeyaraman N, Nallakumarasamy A, Khanna M, Gupta A Cureus. 2023; 15(10):e48032.

PMID: 38034135 PMC: 10687844. DOI: 10.7759/cureus.48032.


Neural mechanisms underlying attentional bias modification in fibromyalgia patients: a double-blind ERP study.

Fernandes-Magalhaes R, Carpio A, Ferrera D, Pelaez I, De Lahoz M, Van Ryckeghem D Eur Arch Psychiatry Clin Neurosci. 2023; 274(5):1197-1213.

PMID: 37980687 DOI: 10.1007/s00406-023-01709-4.


Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results.

MacLean R, Heapy A, Waters A, Wolkowicz N, Szollosy S, Meyerovich J Drug Alcohol Depend. 2023; 246:109857.

PMID: 37004461 PMC: 10189744. DOI: 10.1016/j.drugalcdep.2023.109857.